3D Cell Culture Market worth 1345.2 Million USD by 2021

By -

3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free) by Application (Cancer Research, Stem Cell Technology, Primary Cell Research, Tissue Engineering & Regenerative Medicines, Human Cell Lines, Tumor Xenografting, Drug Discovery, and Other

(EMAILWIRE.COM, October 17, 2017 ) Browse 66 market data Tables and 72 Figures spread through 158 Pages and in-depth TOC on "3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free) by Application (Cancer Research, Stem Cell Technology, Primary Cell Research, Tissue Engineering & Regenerative Medicines, Human Cell Lines, Tumor Xenografting, Drug Discovery, and Others) by End-Users (Research Laboratories, Biotechnology and Pharmaceuticals Industries, Hospitals and Diagnostics Centers and Others) - Global Forecast to 2021"

http://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html

Early buyers will receive 10% customization on reports.

The global 3D cell culture market is steadily progressing owing to various factors, such as increasing research in 3D cell culture, investments done by pharmaceutical and biotechnology companies in 3D cell culture, initiatives undertaken by governments for implementing research in 3D cell culture, and rapid increase in the need for organ transplantation.

3D cell culture is one of the new evolving field of research and technology in the market. It provides a 3D environment to the cells to grow in all directions, providing more accurate results than 2D procedures.

North America accounted for the largest share of the global 3D cell culture market, and was dominated largely by the U.S. Increasing number of organ transplantation and increasing demand of research especially in cancer is driving the U.S. market. Europe is the second-largest market for 3D cell culture with Germany leading the market in the region. The limitations of the global 3D cell culture market are huge investments required in 3D cell culture and lack of professionals in this field.

Major companies operational in the 3D Cell Culture market are 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd, (a subsidiary of ReproCELL) (U.K.), and others.

Request Sample Pages@ http://www.marketsandmarkets.com/requestsample.asp?id=191072847

The research study is aimed at identifying emerging trends and opportunities in the global 3D cell culture market along with detailed classifications, in terms of revenue. It provides a comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global 3D cell culture market on the basis of technology type, application type, end-user, and geography.

Apart from the market segmentation, this report also provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global 3D cell culture market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more